Allogeneic Hematopoietic Cell Transplantation for Aggressive NK-cell Leukemia. A CIBMTR Analysis

Aggressive NK-cell leukemia (ANKL) is an exceedingly rare form of leukemia and carries a poor prognosis with a median survival of only 2-months. Using the Center for International Blood and Marrow Transplant Research database, we evaluated outcomes of allogeneic hematopoietic cell transplantation (a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Hamadani, Mehdi, Kanate, Abraham S., DiGilio, Alyssa, Ahn, Kwang Woo, Smith, Sonali M., Lee, Jong Wook, Ayala, Ernesto, Chao, Nelson, Hari, Parameswaran, Bolaños-Meade, Javier, Gress, Ronald, Anderson, Niels Smedegaard, Chen, Yi-Bin, Farooq, Umar, Schiller, Gary, Yared, Jean, Sureda, Anna, Fenske, Timothy S., Olteanu, Horatiu
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5410937/
https://ncbi.nlm.nih.gov/pubmed/28161608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.01.082
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares